Lifordi Immunotherapeutics

Lifordi Immunotherapeutics is a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory diseases. The company offers a proprietary ADC platform demonstrating enhanced efficacy and safety in disease models, enabling innovative therapies to address unmet needs in immunology and inflammation.